LURAP1L, or Leucine-Rich Adaptor Protein 1-Like, is a protein that plays a significant role in the modulation of signal transduction pathways within cells, particularly those related to cytoskeletal organization and cell migration. As a member of the adaptor proteins, LURAP1L is involved in linking cell surface receptors to specific effectors within the cell, thereby influencing downstream signaling pathways that control cellular dynamics and responses to environmental cues. This function is critical for processes such as cell motility, adhesion, and organization, all of which are essential for tissue development and repair. Moreover, LURAP1L has been implicated in the regulation of cell division, where it potentially coordinates signaling pathways that govern the cytoskeleton during mitosis. The ability of LURAP1L to interact with multiple signaling molecules positions it as a pivotal player in the orchestration of complex cellular responses, making it integral to maintaining cellular integrity and function.
The activation of LURAP1L is a finely tuned process that is regulated by both post-translational modifications and its interaction with other cellular proteins. Typically, the activation involves phosphorylation, which can alter its binding affinity and functional activity, thereby modulating its role in signaling pathways. This phosphorylation is often mediated by specific kinases that are activated in response to extracellular signals or during particular phases of the cell cycle. Additionally, LURAP1L may be activated or deactivated by mechanisms such as ubiquitination, which targets it for degradation, or by sequestration by other proteins that mask its active sites and prevent its participation in signaling pathways. These regulatory mechanisms ensure that LURAP1L's activity is precisely controlled in space and time, enabling the cell to respond adaptively to changes in the internal and external environment. By regulating the activity of LURAP1L, cells can effectively manage processes that are essential for their survival and proper functioning, such as adapting to mechanical stress, migrating toward chemical signals, or proliferating in response to developmental cues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits ALK5, affecting the Smad2/3 pathway. This could disrupt Smad-mediated transcription, possibly modulating genes that are linked with LURAP1L function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor more specific than LY294002. By suppressing PI3K, it hampers downstream Akt activation, possibly making more substrates available for LURAP1L. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor that prevents JNK activation, thereby changing AP-1 transcriptional activity. LURAP1L could be influenced via downstream target proteins. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Chelates intracellular Ca2+, affecting CaMK activation. This could change substrate phosphorylation patterns relevant to LURAP1L. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
CaMKII inhibitor that would suppress CaMKII-mediated phosphorylation events, affecting proteins that interact with LURAP1L. | ||||||
ML 141 | 71203-35-5 | sc-362768 sc-362768A | 5 mg 25 mg | $137.00 $512.00 | 7 | |
Inhibits Cdc42, affecting actin polymerization and subsequent cytoskeletal changes. This could alter LURAP1L's localization or function. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
Inhibits G9a methyltransferase, thereby affecting histone methylation and subsequently genes that LURAP1L might regulate or interact with. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
Inhibits serum and glucocorticoid kinase 1 (SGK1), potentially affecting ion channels and transporters related to LURAP1L function. | ||||||
CK 666 | 442633-00-3 | sc-361151 sc-361151A | 10 mg 50 mg | $321.00 $1040.00 | 5 | |
Inhibits Arp2/3 complex, affecting actin polymerization. This can modify cytoskeletal dynamics that LURAP1L may be involved in. | ||||||